483 GlaxoWellcome Production Mar 2017

483 GlaxoWellcome Production Mar 2017

Patric Klotzbuecher FDA, Bijoy Panicker FDA$119.00 - Available Now

FDA investigators audited the GlaxoWellcome Production - Evreux Cedex 9, France facility and issued inspectional observations (via FDA 483) on 03 Mar 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Mar 2017
  • Location: Evreux Cedex 9, France
  • FEI: 3002807436
Add To Cart